NCT02209532View on ClinicalTrials.gov

A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping

NACompletedINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions

Endometrial CancerUterine CancerCervical Cancer

Interventions

DEVICE

PINPOINT

PINPOINT® Near Infrared Fluorescence Imaging to identify lymph nodes

Trial Locations (8)

Unknown

O'Connor Hospital, San Jose

Lee Memorial Hospital, Fort Myers

Memorial Sloan Kettering, New York

Duke Cancer Institute, Durham

MD Anderson Cancer Center, Houston

Sunnybrook Health Science Centre, Toronto

CHU de Québec - Université Laval, Québec

Hospital HIMA San Pablo, Caguas

All Listed Sponsors

lead

Novadaq Technologies ULC, now a part of Stryker

INDUSTRY

NCT02209532 - A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping | Biotech Hunter | Biotech Hunter